As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and

Join Jeremy Abramson, MD and Jeffrey Barnes, MD as they present their multidisciplinary expertise on a range of cases pertaining to CLL and SLL.

Join Steven Chang, MD and Toni Choueiri, MD as they present their multidisciplinary expertise on a range of cases pertaining to kidney cancer.

Join Amir Behdad, MD and Leo Gordon, MD as they present their multidisciplinary expertise on a range of cases pertaining to mantle cell lymphoma.

Join Leora Horn, MD, MSc, FRCPC and Christine Lovly, MD, PhD as they present their multidisciplinary expertise on a range of cases pertaining to biomarker driven advanced disease lung cancer.

Join Kristine Kokeny, MD and John Ward, MD as they present their multidisciplinary expertise on a range of cases pertaining to adjuvant systemic therapy for breast cancer.

Join Jason Rockhill, MD and John Thompson, MD as they present their multidisciplinary expertise on a range of cases pertaining to advanced disease melanoma.

Join Elias Jabbour, MD, and Susan O'Brien, MD, as they present their multidisciplinary expertise on a range of cases pertaining to chronic myelogenous leukemia. 

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

This live 75-minute webinar, with interactive Q&A and patient-clinician video case studies, will review the basics of immuno-oncology including the role of the immune system, mechanism of action and pathways of immunotherapy, and compare and contrast conventional and immuno-oncologic cancer t